Effect of piracetam, a nootropic agent, on rat brain monoamines and prostaglandins.
Piracetam is the prototype of a new class of psychotropic drugs, the nootropic agents, which are claimed to selectively improve the higher telencephalic integrative activities. The effect of piracetam on rat brain monoamines and prostaglandins (PGs) was assessed so as to garner information on its mode of action. Two doses of the drug were used, a lower dose (20 mg/kg ip) and a higher dose (100 mg/kg, ip), the latter being known to exert a facilitatory effect on learning and memory. Piracetam produced a dose-related effect on rat brain serotonin (5HT) and noradrenaline (NA), with the lower dose inducing a decrease in 5HT levels and an increase in NA concentrations. The higher dose of piracetam produced the opposite effect. Dopamine (DA) levels were not significantly affected. The lower dose of the drug attenuated 5HT turnover and augmented that of NA, whereas the higher dose of piracetam produced the reverse effects, in clorgyline treated rats. The lower dose of piracetam produced a slight and statistically insignificant increase in rat brain PGE2 and PGF2 alpha. However, the higher dose of the drug produced marked increase in the levels of both the PGs. The observed biochemical effects may provide a basis for the nootropic effect of piracetam. However, they may also be due to the GA-BA-mimetic action of the drug, particularly those observed with the lower dose of piracetam.
Bhattacharya
S K
SK
Upadhyay
S N
SN
Jaiswal
A K
AK
Bhattacharya
S
S
D000818:Animals; D015306:Biogenic Monoamines / Q000032:analysis*; D001923:Brain Chemistry / Q000187:drug effects*; D003010:Clorgyline / Q000494:pharmacology; D005260:Female; D008297:Male; D010889:Piracetam / Q000633:toxicity*; D011453:Prostaglandins / Q000032:analysis*; D011760:Pyrrolidinones / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains
D015306:Biogenic Monoamines; D011453:Prostaglandins; D011760:Pyrrolidinones; D003010:Clorgyline; D010889:Piracetam